4//SEC Filing
Subramanian Sanjay 4
Accession 0001209191-22-020519
CIK 0001693011other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:11 PM ET
Size
5.6 KB
Accession
0001209191-22-020519
Insider Transaction Report
Form 4
Subramanian Sanjay
SVP, CFO & Head of BD
Transactions
- Award
Stock option (right to buy)
2022-03-21+180,000→ 180,000 totalExercise: $3.96Exp: 2032-03-20→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]The option was granted on March 21, 2022 and is scheduled to vest 25% on the first anniversary of the grant date. The remainder of the shares underlying the option are scheduled to vest in equal monthly installments over the following three years until the fourth anniversary of the grant date.
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001790246
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:11 PM ET
- Size
- 5.6 KB